Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 2
2009 10
2010 13
2011 18
2012 13
2013 17
2014 19
2015 30
2016 21
2017 20
2018 35
2019 37
2020 33
2021 39
2022 48
2023 56
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Results by year

Filters applied: . Clear all
Page 1
Dynamic blood single-cell immune responses in patients with COVID-19.
Huang L, Shi Y, Gong B, Jiang L, Zhang Z, Liu X, Yang J, He Y, Jiang Z, Zhong L, Tang J, You C, Jiang Q, Long B, Zeng T, Luo M, Zeng F, Zeng F, Wang S, Yang X, Yang Z. Huang L, et al. Among authors: tang j. Signal Transduct Target Ther. 2021 Mar 6;6(1):110. doi: 10.1038/s41392-021-00526-2. Signal Transduct Target Ther. 2021. PMID: 33677468 Free PMC article.
VEGF-B Promotes Endocardium-Derived Coronary Vessel Development and Cardiac Regeneration.
Räsänen M, Sultan I, Paech J, Hemanthakumar KA, Yu W, He L, Tang J, Sun Y, Hlushchuk R, Huan X, Armstrong E, Khoma OZ, Mervaala E, Djonov V, Betsholtz C, Zhou B, Kivelä R, Alitalo K. Räsänen M, et al. Among authors: tang j. Circulation. 2021 Jan 5;143(1):65-77. doi: 10.1161/CIRCULATIONAHA.120.050635. Epub 2020 Nov 18. Circulation. 2021. PMID: 33203221 Free article.
Effect of Rivaroxaban vs Enoxaparin on Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of Acute Coronary Syndrome: The H-REPLACE Randomized Equivalence and Noninferiority Trial.
Zhou S, Xiao Y, Zhou C, Zheng Z, Jiang W, Shen Q, Zhu C, Pan H, Liu C, Zeng G, Ge L, Zhang Y, Ouyang Z, Fu G, Pan G, Chen F, Huang L, Liu Q; H-REPLACE Investigators. Zhou S, et al. JAMA Netw Open. 2023 Feb 1;6(2):e2255709. doi: 10.1001/jamanetworkopen.2022.55709. JAMA Netw Open. 2023. PMID: 36763358 Free PMC article. Clinical Trial.
Enhancing the precision of genetic lineage tracing using dual recombinases.
He L, Li Y, Li Y, Pu W, Huang X, Tian X, Wang Y, Zhang H, Liu Q, Zhang L, Zhao H, Tang J, Ji H, Cai D, Han Z, Han Z, Nie Y, Hu S, Wang QD, Sun R, Fei J, Wang F, Chen T, Yan Y, Huang H, Pu WT, Zhou B. He L, et al. Among authors: tang j. Nat Med. 2017 Dec;23(12):1488-1498. doi: 10.1038/nm.4437. Epub 2017 Nov 13. Nat Med. 2017. PMID: 29131159 Free PMC article.
A suite of new Dre recombinase drivers markedly expands the ability to perform intersectional genetic targeting.
Han X, Zhang Z, He L, Zhu H, Li Y, Pu W, Han M, Zhao H, Liu K, Li Y, Huang X, Zhang M, Jin H, Lv Z, Tang J, Wang J, Sun R, Fei J, Tian X, Duan S, Wang QD, Wang L, He B, Zhou B. Han X, et al. Among authors: tang j. Cell Stem Cell. 2021 Jun 3;28(6):1160-1176.e7. doi: 10.1016/j.stem.2021.01.007. Epub 2021 Feb 9. Cell Stem Cell. 2021. PMID: 33567267 Free article.
Interpretable machine learning for 28-day all-cause in-hospital mortality prediction in critically ill patients with heart failure combined with hypertension: A retrospective cohort study based on medical information mart for intensive care database-IV and eICU databases.
Peng S, Huang J, Liu X, Deng J, Sun C, Tang J, Chen H, Cao W, Wang W, Duan X, Luo X, Peng S. Peng S, et al. Among authors: tang j. Front Cardiovasc Med. 2022 Oct 12;9:994359. doi: 10.3389/fcvm.2022.994359. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36312291 Free PMC article.
374 results